Health-related quality of Life in patients with chronic hepatitis C receiving Sofosbuvir-based treatment, with and without Interferon: a prospective observational study in Egypt

BACKGROUND: The Egyptian government introduced the first directly acting antivirals (DAAs) into Egypt through the government funded National Treatment Program. As yet, there has been no investigation into the effects of these new DAAs therapies on patient reported outcomes (PROs). This study aimed t...

Descripción completa

Detalles Bibliográficos
Autores principales: Youssef, Naglaa F. A., El Kassas, Mohamed, Farag, Amany, Shepherd, Ashley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5251342/
https://www.ncbi.nlm.nih.gov/pubmed/28109264
http://dx.doi.org/10.1186/s12876-017-0581-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5251342/
https://www.ncbi.nlm.nih.gov/pubmed/28109264
http://dx.doi.org/10.1186/s12876-017-0581-1

Ejemplares similares